Medical and Scientific Advisors

FCF strives to be in the forefront of research on fibrolamellar carcinoma (FLC). Listed below are leading physicians, scientists and researchers who are experienced with FLC and have agreed to be advisors to the Fibrolamellar Cancer Foundation. Each represents an institution or laboratory which is currently involved in research or treatment of fibrolamellar liver cancer.

These advisors, working closely with FCF’s Chief Science Officer (Mark Furth, PhD) and FCF’s Research Program Director (Payal Ray, PhD), provide strategic direction for our research programs and play a key role in guiding and prioritizing FCF’s research investments.

Medical & Scientific Advisory Board (MSAB)

Ghassan Abou-Alfa, MDMedical Oncologist
Gastrointestinal Oncology
Memorial Sloan Kettering Cancer Center
New York, NY
John Gordan, MD, PhDAssistant Professor
Hematology and Oncology
University of California, San Francisco (UCSF)
San Francisco, CA
Elizabeth M. Jaffee, MDDeputy Director, Sidney Kimmel Comprehensive Cancer Center
Professor of Oncology, Bloomberg-Kimmel Institute for Immunotherapy
Johns Hopkins University
Baltimore, MD
Razelle Kurzrock, MDProfessor of Medicine
Associate Director of Clinical Research, Medical College of Wisconsin Cancer Center
Center Associate Director, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine
Founding Director, Michels Rare Cancers Research Laboratories
Medical College of Wisconsin
Milwaukee, WI
Allison F. O’Neill, MDDirector, Pediatric Liver Tumor Program
Dana-Farber Cancer Institute
Boston Children’s Hospital
Harvard Medical School
Boston, MA
John D. Scott, PhDEdwin G. Krebs – Speights Professor of Cell Signaling and Cancer Biology
Chairman, Department of Pharmacology
University of Washington School of Medicine
Seattle, WA
Mark Yarchoan, MDAssociate Professor of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Baltimore, MD
Jessica Zucman-Rossi, MD, PhDProfessor of Oncology
Director, INSERM Unit “Functional Genomics of Solid Tumors”
Université Paris Descartes
Paris, France

MSAB Members Emeritus

John Craig, MD, PhDMedical Director (retired)
St. Jude Medical Center
Fullerton, CA

Member, Board of Directors
Fibrolamellar Cancer Foundation
Lola Reid, PhDProfessor
Department of Cell Biology and Physiology
University of North Carolina
Chapel Hill, NC